Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaro Ohara

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Translational Oncology|November 15, 2020
Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncologyShaham Beg, Rohan Bareja, Kentaro Ohara, et al.
Nature Communications|March 19, 2024
The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysisKentaro Ohara, André Figueiredo Rendeiro, Bhavneet Bhinder, et al.
The Oncologist|July 21, 2021
Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma TestingWael Al Zoughbi, Jesse Fox, Shaham Beg, et al.
Science Advances|June 26, 2026
Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilitiesHui-Hsuan Kuo, Bhavneet Bhinder, Hamza N Gokozan, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Translational Oncology|November 15, 2020
Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncologyShaham Beg, Rohan Bareja, Kentaro Ohara, et al.
Nature Communications|March 19, 2024
The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysisKentaro Ohara, André Figueiredo Rendeiro, Bhavneet Bhinder, et al.
The Oncologist|July 21, 2021
Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma TestingWael Al Zoughbi, Jesse Fox, Shaham Beg, et al.
Science Advances|June 26, 2026
Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilitiesHui-Hsuan Kuo, Bhavneet Bhinder, Hamza N Gokozan, et al.
Pageof 7